Abstract: A process for producing a reinforcing woven fabric includes sticking a resin material on at least one surface of a fabric substrate including a plurality of reinforcing fiber bundles and varying the relative position of a plurality of reinforcing fiber bundles to peel the resin material stuck over two or more reinforcing fiber bundles from a part of the two or more reinforcing fiber bundles.

Abstract: A process for manufacturing a preform, and apparatus therefor, wherein a preform with a branched portion in its cross-section profile is continuously manufactured by delivering a raw form of reinforcing fiber base material with a branched portion in its cross-section profile, among multiple reinforcing fiber base materials for constructing the preform, intermittently in the longitudinal direction thereof; at each delivery discontinuation, performing heat and/or pressure application to the raw base material so as to tentatively obtain a preliminary shaped matter with given configuration; and uniting the obtained preliminary shaped matter with given configuration with raw forms of other reinforcing fiber base materials for constructing the preform.

Abstract: To provide a reinforcing woven fabric, which is excellent in deformability, capable of following a complicated shape and excellent in retention of the shape, and a preform using it, a fiber reinforced plastic molded component and a process for producing them. Provided is a reinforcing woven fabric where a resin material is stuck on at least one surface of a fabric substrate containing a plurality of reinforcing fiber bundles, then the resin material stuck over two or more reinforcing fiber bundles is peeled from a part of the two or more reinforcing fiber bundles by varying the relative position of a plurality of reinforcing fiber bundles constituting the fabric substrate, wherein the maximum value of load till a tensile strain in a non fiber axial tensile test reaches 1% is in a range of 0.01 to 0.75 N.

Abstract: The present invention relates to an ether derivative represented by the formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof wherein each symbol is as defined in the description, and an ether derivative represented by the formula (III), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof wherein each symbol is as defined in the description; a pharmaceutical composition containing the ether derivative; and a package containing the pharmaceutical composition and a description of use thereof. A pharmaceutical composition of the present invention, which contains this compound of the present invention has a superior anti-inflammatory and analgesic activity and is useful as various pharmaceutical agents such as an anti-inflammatory agent, an analgesic, a therapeutic agent for inflammatory bowel disease, a therapeutic agent for pollakiuria and/or incontinentia, a therapeutic agent for asthma and the like.

Abstract: A preform for the molding of a fiber-reinforced resin beam, the preform comprising: a reinforcing-fiber beam which has been formed from a reinforcing-fiber base made up of many reinforcing fibers and has a cross-sectional shape comprising at least one linear part and at least one curved part connected to the linear part; and a release sheet bonded and united through an adhesive resin to at least part of a surface of the reinforcing-fiber base along the lengthwise direction for the base. A process for producing a preform comprises: a step in which a continuous flat reinforcing-fiber base having a release sheet bonded and united to a surface thereof is shaped so that the cross-sectional shape of the base comes to have a curved part to thereby produce a preshaped object; and a preshaped-object uniting step in which the preshaped object is bonded and united to another preshaped object.

Abstract: A method for preparing a phenylalanine derivative having a quinazoline-dione ring represented by the following formula (1) or a pharmaceutically acceptable salt thereof, comprising the following steps (a), (b) and (c): (a) reacting an acyl phenylalanine derivative represented by the following formula (2): with a carbonyl group-introducing reagent and a specific anthranilic acid derivative to thus form the corresponding carboxy-asymmetric urea derivative; (b) converting the carboxy-asymmetric urea derivative into the corresponding quinazoline-dione derivative in the presence of a carboxyl group-activating agent: (c) if desired, substituting an N-alkyl group for the hydrogen atom bonded to the nitrogen atom present in the quinazoline-dione ring of the quinazoline-dione derivative using an N-alkylation agent and then deprotecting the resulting product, when the substituent R3? which is a group corresponding to R3 is protected.

Abstract: Amide derivatives represented by the formula (I): wherein: A is a cycloalkyl group, an aryl group or a heteroaryl group; X is a nitrogen atom or CR17; Y is —NRa—, —(CRbRb?)m-, and the like; m is 0 to 4; and R1 to R17 may be the same or different and each is a hydrogen atom, a halogen atom, a cyano group, a nitro group, a carboxyl group, a formyl group, a hydroxyl group, an ammonium group, an alkyl group optionally having one or more substituents, -ZR18 and the like, Z is —O—, —S(O)p-, —S(O)pO—, —NH—, —NR19-, and the like; or a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof may be applied to pharmaceutical use such as anti-inflammatory and analgesic action and the like.

Abstract: Amide derivatives represented by the formula (I): wherein: A is a cycloalkyl group, an aryl group or a heteroaryl group; X is a nitrogen atom or CR17; Y is —NRa—, —(CRbRb?)m-, and the like; m is 0 to 4; and R1 to R17 may be the same or different and each is a hydrogen atom, a halogen atom, a cyano group, a nitro group, a carboxyl group, a formyl group, a hydroxyl group, an ammonium group, an alkyl group optionally having one or more substituents, ZR18 and the like, Z is —O—, —S(O)p-, —S(O)pO—, —NH—, —NR19-, and the like; or R1 and R2 may in combination form a ring, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof may be applied to pharmaceutical use such as anti-inflammatory and analgesic action and the like.

Abstract: A method of forming, on a strip-shaped laminate of multiple reinforcing fiber sheets superimposed one upon another, two flexures with respect to the cross-section configuration thereof, wherein in the forming of the two flexures with the use of two flexure forming dies independent from each other, respectively, the two flexure forming dies are arranged so that the relative distance of the two flexure forming dies is changeable in the direction perpendicular to the longitudinal direction of the strip-shaped laminate. This method can be effectively utilized in the production of a reinforcing fiber molding with changing of the distance between the two flexures namely, width of web portion or gauge between two flange portions from the strip-shaped laminate, or the production of fiber reinforced resin (FRP) molding therefrom.

Abstract: A process for manufacturing a preform, and apparatus therefor, wherein a preform with a branched portion in its cross-section profile is continuously manufactured by delivering a raw form of reinforcing fiber base material with a branched portion in its cross-section profile, among multiple reinforcing fiber base materials for constructing the preform, intermittently in the longitudinal direction thereof; at each delivery discontinuation, performing heat and/or pressure application to the raw base material so as to tentatively obtain a preliminary shaped matter with given configuration; and uniting the obtained preliminary shaped matter with given configuration with raw forms of other reinforcing fiber base materials for constructing the preform.

Abstract: To provide a reinforcing woven fabric, which is excellent in deformability, capable of following a complicated shape and excellent in retention of the shape, and a preform using it, a fiber reinforced plastic molded component and a process for producing them. Provided is a reinforcing woven fabric where a resin material is stuck on at least one surface of a fabric substrate containing a plurality of reinforcing fiber bundles, then the resin material stuck over two or more reinforcing fiber bundles is peeled from a part of the two or more reinforcing fiber bundles by varying the relative position of a plurality of reinforcing fiber bundles constituting the fabric substrate, wherein the maximum value of load till a tensile strain in a non fiber axial tensile test reaches 1% is in a range of 0.01 to 0.75 N.

Abstract: Specific phenylalanine derivatives and analogues thereof have an antagonistic activity to ?4 integrin. They are used as therapeutic agents for various diseases concerning ?4 integrin.

Abstract: Specific phenylalanine derivatives and analogues thereof have an antagonistic activity to ?4 integrin. They are used as therapeutic agents for various diseases concerning ?4 integrin.

Abstract: The present invention relates to an ether derivative represented by the formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof wherein each symbol is as defined in the description, and an ether derivative represented by the formula (III), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof wherein each symbol is as defined in the description; a pharmaceutical composition containing the ether derivative; and a package containing the pharmaceutical composition and a description of use thereof. A pharmaceutical composition of the present invention, which contains this compound of the present invention has a superior anti-inflammatory and analgesic activity and is useful as various pharmaceutical agents such as an anti-inflammatory agent, an analgesic, a therapeutic agent for inflammatory bowel disease, a therapeutic agent for pollakiuria and/or incontinentia, a therapeutic agent for asthma and the like.

Abstract: Amide derivatives represented by the formula (I): wherein: A is a cycloalkyl group, an aryl group or a heteroaryl group; X is a nitrogen atom or CR17; Y is —NRa—, —(CRbRb?)m—, and the like; m is 0 to 4; and R1 to R17 may be the same or different and each is a hydrogen atom, a halogen atom, a cyano group, a nitro group, a carboxyl group, a formyl group, a hydroxyl group, an ammonium group, an alkyl group optionally having one or more substituents, ZR18 and the like, Z is —O—, —S(O)p—, —S(O)pO—, —NH—, —NR19—, and the like; or R1 and R2 may in combination form a ring, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof may be applied to pharmaceutical use such as anti-inflammatory and analgesic action and the like.

Abstract: A method for forming a glossy image comprising: using (A) a heat transfer sheet comprising a substrate, a light-heat conversion layer and an image forming layer in this order, wherein the light-heat conversion layer comprises a polyamide-imide resin, and the image forming layer comprises at least one of tabular inorganic compound particles and metal particles and a thixotropic agent, (B) a heat transfer sheet comprising a substrate, a light-heat conversion layer and an image forming layer in this order, wherein the light-heat conversion layer comprises a polyamide-imide resin, and the image forming layer comprises a transparent colorant, and (C) an image receiving sheet comprising an image receiving layer; and imagewise transferring the image forming layer of each of the heat transfer sheet (A) and the heat transfer sheet (B) to the image receiving layer by laser thermal transfer.

Abstract: A feeding apparatus aimed at efficiently supplying feed to chicks in a chick box, which can hold the feed in the chick box and can supply the feed to the chicks in the chick box, wherein the feed is supplied to the chicks in the chick box by means of a feeding apparatus which can maintain the feed at the height of the chicks' beaks when they are standing.

Abstract: Specific phenylalanine derivatives and analogues thereof have an antagonistic activity to ?4 integrin. They are used as therapeutic agents for various diseases concerning ?4 integrin.

Abstract: An image-forming material comprising: an image-receiving sheet comprising an image-receiving layer and a support; and a thermal transfer sheet comprising a light-to-heat conversion layer, an image-forming layer and a support, which is used with laser light, wherein at least one layer in at least one of the image-receiving sheet and the thermal transfer sheet comprises a copolymer comprising monomers represented by the formulae (a), (b) and (c) as defined herein.

Abstract: An image-forming material comprising: an image-receiving sheet comprising an image-receiving layer and a support; and a thermal transfer sheet comprising a light-to-heat conversion layer, an image-forming layer and a support, which is used with laser light, wherein at least one layer in at least one of the image-receiving sheet and the thermal transfer sheet comprises a copolymer comprising monomers represented by the formulae (a), (b) and (c) as defined herein.